Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Gambogicacid derivative and its preparation method and uses in pharmacy

A Derivative, Gambogic Acid Technology, Applied in Pharmaceutical Field

Inactive Publication Date: 2006-12-13
CHINA PHARM UNIV
View PDF2 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there is no report on the synthesis of nitric oxide donor-type gambogic acid derivatives using NO donors and gambogic acid

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Gambogicacid derivative and its preparation method and uses in pharmacy
  • Gambogicacid derivative and its preparation method and uses in pharmacy
  • Gambogicacid derivative and its preparation method and uses in pharmacy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0064] Embodiment 1: Gambogic acid-2'-nitrooxyethyl ester (I-1)

[0065] Dissolve 250mg (0.4mmol) of gambogic acid in 15ml of acetone, add 0.18ml (2.08mmol) of dibromoethane and 0.4ml of triethylamine respectively at room temperature, the reaction solution is yellow and transparent, after the addition, reflux for 6 hours , concentrated the reaction solution directly, put it on the column by dry method, column chromatography, eluting with petroleum ether / ethyl acetate (4:1), and prepared 80 mg of yellow oil (A-1) with a yield of about 27%. Then, 80mg (0.11mmol) of compound (A-1) was dissolved in 10ml (1:1) of anhydrous tetrahydrofuran and acetonitrile mixed solvent, and 28mg (0.17mmol) of silver nitrate was added at room temperature, and the reaction was done under reflux in the dark for 5 hours. , the reaction solution was filtered to remove the precipitate, the filtrate was concentrated, put on the column by dry method, column chromatography, petroleum ether / ethyl acetate (4:...

Embodiment 2

[0069] Embodiment 2: Gambogic acid-3'-nitrooxypropyl ester (I-2)

[0070] With reference to the preparation method of compound (A-1), the yellow oil (A-2 ) 750mg, yield 95%. Referring to the preparation method of compound I-1, 710 mg (0.95 mmol) of compound (A-2) and 242 mg (1.43 mmol) of silver nitrate were refluxed and reacted, and the aftertreatment was the same as above to obtain 140 mg of yellow sticky substance (I-2). Yield 20%.

[0071] IR(KBr): v=3456, 2967, 2924, 2858, 1736, 1710, 1632, 1593, 1438, 1383, 1331, 1279, 1228, 1177, 1140, 1048cm -1 .

[0072] 1 HNMR (300M, CDCl 3 ): δ12.86(1H, s, 6-OH), 7.56(1H, brs, H-10), 6.67(1H, m, H-4), 6.14(1H, m, H-27), 5.45( 1H, m, H-3), 5.06 (2H, m, H-32, H-37), 4.39 ((2H, m, H-1'), 3.90 (2H, m, H-3'), 3.48 (3H, m, H-2', H-11), 3.30 (1H, m, H-31a), 3.23 (1H, m, H-31b), 2.98 (2H, dd, J=9.7Hz, 7.9Hz , H-26), 2.52 (1H, m, H-22), 2.36 (1H, dd, J=13.0Hz, 4.6Hz, H-21a), 2.03 (2H, m, H-36), 1.75 (3H , s, H-25), 1.72 (2H, m, H-20...

Embodiment 3

[0074] Embodiment 3: Gambogic acid-4'-nitrooxybutyl ester (I-3)

[0075] With reference to the preparation method of compound (A-1), yellow oil (A -3) 630mg, yield 83%. Referring to the preparation method of compound (I-1), 630mg (1.22mmol) of compound (A-3) and 311mg (1.83mmol) of silver nitrate were refluxed, and the aftertreatment was the same as above to obtain a yellow sticky substance (I-3) 160 mg, yield 39%.

[0076] IR(KBr): v=3455, 2967, 2924, 2858, 1736, 1710, 1632, 1593, 1438, 1382, 1331, 1278, 1228, 1176, 1140, 1048cm -1 .

[0077] 1 HNMR (300M, CDCl 3 ): δ12.86(1H, s, 6-OH), 7.56(1H, brs, H-10), 6.67(1H, m, H-4), 6.11(1H, m, H-27), 5.45( 1H, m, H-3), 5.07 (2H, m, H-32, H-37), 4.54 ((2H, m, H-1'), 3.53 (4H, m, H-2', H- 3'), 4.10 (2H, m, H-4'), 3.48 (1H, m, H-11), 3.30 (1H, m, H-31a), 3.21 (1H, m, H-31b), 2.98 (2H, dd, J=9.7Hz, 7.9Hz, H-26), 2.51 (1H, m, H-22), 2.36 (1H, dd, J=13.0Hz, 4.6Hz, H-21a), 2.02( 2H, m, H-36), 1.75 (3H, s, H-25), 1.71 (2H, m, H-20)...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses the preparing method and application of cambogic acid derivation. The cambogic acid derivation is made by nitric oxide donator and cambogic acid. The cambogic acid derivation has the antineoplastic action.

Description

technical field [0001] The invention belongs to the field of pharmacy, and relates to a gambogic acid derivative with anti-tumor effect, specifically a compound that uses different types of nitric oxide (abbreviated as NO) donors to couple gambogic acid through an ester bond or an amide bond , the present invention also relates to the preparation method and application of the derivative in pharmacy. Background technique [0002] Gambogic acid, a natural compound, was isolated for the first time from the garcinia resin of plants of the genus Garcinia. Gambogic acid can selectively and effectively kill tumor cells, but has no effect on normal hematopoietic system and immune function. Studies have proved that gambogic acid and its derivatives are agonists of caspases and inducers of apoptosis , can be used as an effective inducer of apoptosis against various tumor lines. [0003] Because gambogic acid and its derivative compounds have significant cytotoxicity, in order to fin...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D498/22C07D493/20C07D493/18A61K31/4245A61K31/352A61P35/00
Inventor 尤启冬王进欣郭青龙
Owner CHINA PHARM UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com